Bruce H. Cohen, MD, FAAn

Bruce H. Cohen, MD, FAAN, is the director of the NeuroDevelopmental Science Center and Director of Scientific Affairs and Clinical Trials of the Rebecca D. Considine Research Institute at The Children’s Hospital Medical Center of Akron, and professor of pediatrics and professor of integrative medical sciences at Northeast Ohio Medical University. He holds the Phillip H. Maynard Chair in NeuroDevelopmental Sciences. Cohen attended Washington University, graduating summa cum laude with a BA in chemistry. He attended the Albert Einstein College of Medicine of Yeshiva University.

Following pediatric training at The Children’s Hospital of Philadelphia, he did his neurology training at the Neurological Institute of New York, before returning to Children’s Hospital of Philadelphia for a fellowship in pediatric neuro-oncology. He spent the next two decades at The Cleveland Clinic, serving as a pediatric neurologist, neuro-oncologist, and practicing neurogenetics before moving to Akron Children’s Hospital in 2011 to pursue work in clinical trials. His clinical practice is centered on caring for children and adults with mitochondrial disorders, neurogenetic illness, and brain tumors, and he has a busy clinical research practice. His administrative responsibilities dovetail into his academic and practical interests in health care economics and health care delivery models.

Cohen’s academic career initially involved clinical trials for treatment of brain tumors in infants and children, and then transitioned in the emerging field of mitochondrial medicine. He also developed an interest in health care economics and practice management in the early 1990s. Cohen has served as chair of the Child Neurology Section of the American Academy of Neurology, chair of the Practice Committee of the Child Neurology Society, and chair of the Coding Subcommittee of the Medical Economics and Management Committee of the AAN. He has served as secretary-treasurer, and currently serves as president of the Child Neurology Society. In 2010, he joined the AAN’s CPT team and became the lead advisor to the CPT Panel from 2016–2022. In 2021, he took on two new additional roles within the AAN: chair of the Advocacy Committee (which includes all the subcommittees covering the legislative and regulatory work) and a seat on the Board of Directors. Cohen has participated in the education of dozens of neurology residents and fellows; led over a dozen international symposia; organized and conducted investigator-initiated clinical trials in brain tumors, neurofibromatosis, and mitochondrial disorders; and has authored 130 peer-reviewed manuscripts and delivered 670 invited lectures.